Change Control: The Most Boring Topic That Can Make Or Break Your Life Science Company
Quality vs. Operations: The Most Expensive Rivalry in Life Sciences
D’OH! So you’ve got a 483. What’s next?
https://www.linkedin.com/pulse/doh-so-youve-got-483-whats-next-joanne-starkey-xopnc
PFAS in Cosmetics: The FDA Speaks
https://www.linkedin.com/pulse/pfas-cosmetics-fda-speaks-joanne-starkey-cwcpc
Compliance Goals for 2026: The Year We Get Ahead
https://www.linkedin.com/pulse/compliance-goals-2026-year-we-get-ahead-joanne-starkey-zg8gc
AI in eQMS: Bridging the Gap Between Capability and Compliance
FDA Warning Letters: What They Mean, How to Respond, and How to Avoid Them In the First Place
FDA’s Shift from QSR to QMSR: What It Means and How to Prepare
https://www.linkedin.com/pulse/fdas-shift-from-qsr-qmsr-what-means-how-prepare-joanne-starkey-o6ybc
Big Talent Need, Small Talent Budget: The Power of Fractional Leadership in Life Sciences
“May You Live in Interesting Times”: The Curse of Uncertainty for GxP Regulated Industries
FDA Releases 2025 Investigations Operations Manual: What It Means for Your Next Inspection
https://www.linkedin.com/pulse/fda-releases-2025-investigations-operations-manual-what-starkey-eei3c
The Emerging Role of AI in Electronic Quality Management Systems for FDA and ISO-Compliant Companies
Does Your Current Org Chart Have Quality Issues?
https://www.linkedin.com/pulse/does-your-current-org-chart-have-quality-issues-joanne-starkey-elopc
The Case for a Fractional Chief Quality Officer (CQO)
https://www.linkedin.com/pulse/case-fractional-chief-quality-officer-cqo-joanne-starkey-mqytc